Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 apiece after investors mimicked the recent selling of three company executives.

A non-exempt employee qualifies to earn at least minimum wage and receive overtime under the federal Fair Labor Standards Act (FLSA).